Bio-link Australia Pty. Ltd.

Collaboration Opportunities

Bio-Link is pursuing strategic collaborative partners for the following opportunities.

Heptares Therapeutics

Heptares Therapeutics, clinical-stage company creating transformative medicines targeting GPCRs,  has engaged Bio-Link to identify Australian expertise and collaborators with an interest and track record of clinical translation of developmental drug candidates.  Heptares’ clinical indications of interest include but are not restricted to, neurological and psychological diseases, cancer, diseases associated with pathogenic glucose metabolism, and chronic inflammation.

Summary (PDF)